Search

everythinglearnresearchcommunity

for

Search:↓

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

Valproic acid treatment increases a specific acid in urine by blocking an enzyme, possibly causing skin rash and hair loss.

Mice with autoimmune hair loss showed signs of heart problems.

Genetic testing is crucial for diagnosing and treating acrodermatitis enteropathica effectively.

Vitamin D receptor is essential for healthy bones and skin.

Azelaic acid is effective for treating rosacea, acne, and melasma.

Growth hormone therapy can improve symptoms and growth in children with Vitamin-D Dependent Rickets Type-2.

Gene therapy helped rats with a specific type of rickets grow hair without severe inflammation.

Adipose tissue-derived therapies show promise for improving osteoarthritis symptoms but need more research for safety and effectiveness.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Adalimumab may cause severe hair loss in some patients.

Valproic acid can cause mild side effects like anorexia and hair loss in some epileptic patients.

Zinc deficiency in alcoholic cirrhosis patients causes skin issues, and zinc treatment improves symptoms.

Zinc supplements improved the girl's skin and hair condition.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Intralesional vitamin D is mildly effective for treating Alopecia Areata.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

The availability of certain hormones and specific stimulation patterns affect long-term synaptic changes in the male rat brain.

Men with male pattern baldness have increased arterial stiffness.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Strontium zinc silicate may help treat osteoporosis and muscle loss.

Argininosuccinic aciduria can cause hair loss.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Gene linked to common hair loss found, may lead to new treatments.